2023 Interim Results Highlights:Steady growth of business, total revenue was RMB97.06 billion, representing a year-on-year increase of 10.9%Significant improvement in core businesses, industrial operation profit was RMB3.37 billion, representing a year-on-year increase of 66%Driving development with technologyInnovation, R&D investment reached RMB4.2 billionRobust mom

(August 29 2023, Shanghai, China) On August 29, 2023, Shanghai Fosun Pharmaceutical Co., Ltd.* (Stock Code: 600196.SH; 02196.HK)announced its 2023 Interim Results for the first half of 2023. (the “Reporting Period”). During the Reporting Period, Fosun Pharma achieved revenue of RMB21.395 billion; the net profit attributable to shareholders of the listed company was

From August 16 to 18, Medlab Asia 2023 was staged in Bangkok, Thailand.As the most influential exhibition for clinical laboratory medicine in Asia, this year's Medlab Asia brought together 350-plus exhibitors from more than 50 countries and regions and at least 7,500 professional visitors, providing a unique platform for medical and laboratory

(28 August 2023, Hong Kong) Hong Kong Quality Assurance Agency (“HKQAA”) held the Hong Kong Green and Sustainability Contribution Awards 2023on 25 August. Fosun International was awarded the Pioneering Award for ESG Disclosure Contributionby HKQAA, in recognition of the company's performance in environmental, social, governance and sustainable development

Results Highlights:Business Volume of the Group’s tourism operation increased by 29.0% year-on-year to RMB9,488.0 million, while revenue grew by 38.7% to RMB8,898.8 million.Losses were turned into profits, achieving a net profit attributable to equity holders of the Company of RMB471.8 million.Club Med'sBusiness Volumesurpassed pre-pandemic levels, with strong growth

Shanghai, China, August 25th, 2023 - Henlius (2696.HK) announced its 2023 interim results.In the first half of 2023, Henlius reported a boost in operating profits of RMB240.0 million and revenues of RMB2.5005 billion, up by 93.9% YoY, driven by growth in core oncology products.HANQUYOU (trastuzumab) and HANSIZHUANG (anti-PD-1 mAb) recorded sales of RM

Expanding Sisram's Ecosystem Offerings and Increasing Direct Sales ReachHONG KONG,Aug. 23, 2023/PRNewswire/ -- Sisram Medical Ltd (the "Company"or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business build

(21 August 2023, Hong Kong) Hong Kong’s first Chinese financial newspaper, Hong Kong Economic Journal (HKEJ) announced the list of companies with outstanding ESG performance on 18 August. Fosun International was awarded the “ESG Achievement Programme 2023” logo and certificate of appreciation by HKEJ, in recognition of the company's performance in environmental,

On 20 August 2023, the final of the Fudan MBA iLab Business Challenge was held in AIA Hall, School of Management, Fudan University. This year's challenge was centered around two major themes: technology innovation and ESG (environmental, social and governance). On the social front of ESG, Fosun Foundation proposed the research topic of "empowering